05.13.26 -- How Commercial Leaders Can Optimize Their Relationships With The Board

Senior experts from the HRA, the ISRCTN Registry (BMC), and Quotient Sciences discuss the implications of New UK regulations for clinical trial registration for sponsors and how to maintain compliance.

Unveil the causes of high screen fail rates, their impact on patient recruitment for clinical trials, and how they disproportionately impact underrepresented demographics.

This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.

Learn about a premier life sciences hub, attracting major biopharma leaders, entrepreneurs, and investors to accelerate global medical innovation.

Module Type Package enables plug‑and‑produce manufacturing through standardized interfaces. It simplifies integration, reduces engineering effort, and helps manufacturers reconfigure production.

Digital transformation begins with a clear framework. Explore a Maturity Model 3.0 that helps biomanufacturers assess and advance digital capabilities, enabling smarter decisions and long-term innovation.

Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.

Pre-filled syringes are a fast-growing pharma segment, improving patient safety and reducing manufacturing costs — but filling them isn’t simple, with distinct technical hurdles to overcome.